HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tom Gallen

Managing Editor – Europe

Having joined OTC bulletin as a business reporter in 2013, Tom is currently the managing editor and has an intimate knowledge of the global consumer healthcare market, particularly commercial and regulatory issues. He specializes in analyzing the strategies of the world's leading consumer healthcare companies, their business performance, plans and product portfolios.
Advertisement
Set Alert for Articles By Tom Gallen

Latest From Tom Gallen

Cannabis Industry Taking Legal Action Against EU Regulators Over CBD Novel Food Classification

The Cannabis Trades Association UK has initiated legal proceedings to challenge the European Commission's recent decision to classify CBD as a novel food. Meanwhile, the UK government has released an official response to the EU's decision. 
Dietary Supplements Legal Issues

OTCs Under Threat In Europe: Calls To Reverse-Switch Codeine And Others In Poland And Ireland

Poland's ministry of health is calling for codeine, dextromethorphan and pseudoephedrine to be reverse-switched from OTC to prescription status in response to abuse of the drugs by adolescents. At the same time, an academic paper argues Ireland should restrict codeine to prescription-only sale to combat an addiction epidemic "verging on eruption."
Prescription To Otc Switch Poland

OTC Marketing Awards 2019 Winners Announced – GSK Crowned Company Of The Year, Pfizer’s Viagra Takes Best Brand

GSK, Pfizer, HRA Pharma and Mentholatum all enjoyed a particularly fruitful evening at the OTC Marketing Awards 2019. J&J, P&G and RB were also among the winners at a celebration of the best and brightest in the UK consumer health market. 
Ad Campaigns Launches

Net Revenue Management - Are You Leaving Money On The Table?

Consumer health players risk missing deserved revenue and profits by failing to take a holistic approach to net revenue management. In this exclusive interview, Simon-Kucher & Partners’ Josh Goodman explains how effective NRM can have a big impact on sales and profits by ensuring full capture of willingness to pay, maximizing promotion ROI, incentivizing beneficial trade terms, prioritizing appropriate channel presence, and capturing all relevant customer purchase occasions. Goodman offers his top tips for small NRM hygiene factors that can make a big difference.

Business Strategies Pricing Strategies

East Meets West – Reckitt Applying Lessons From China To Lead The Way In E-commerce

With online now accounting for 60% of RB's consumer health sales in China, the UK-based company is applying lessons learnt about e-commerce in the Far-East on a global scale. Through its new consumer health e-commerce organisation, e-RB, the firm is prioritizing online growth and seeking to build a leadership position ahead of its peers. 
E-Commerce Business Strategies

Australian Competition Watchdog Probes GSK/Pfizer Consumer Health JV Proposal

Assessing how closely GSK's OTC brands including Panadol compete with Pfizer's Robitussin and other OTC brands is the aim of investigation by Australia's Competition and Consumer Commission into the pharma giants' proposed consumer health joint venture. ACCC states particular interest in importance of Panadol, Voltaren and Advil brands, and whether GSK and Pfizer compete closely in supply of pain relief, gastrointestinal and cold and flu relief products.

M & A Regulation
See All
Advertisement
UsernamePublicRestriction

Register